These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Development and validation of models for predicting the response to intensive induction chemotherapy in acute non-lymphoblastic leukemia]. Sanz MA, Lorenzo JI. Sangre (Barc); 1987; 32(5):463-9. PubMed ID: 3424049 [No Abstract] [Full Text] [Related]
3. [Importance of changes in potassium in the management of patients with acute non-lymphoblastic leukemia]. Marazuela M, Díaz-Mediavilla J, Martínez R, del Potro E, Alvarez A, Espinós D. Med Clin (Barc); 1986 Dec 13; 87(20):843-6. PubMed ID: 3807453 [No Abstract] [Full Text] [Related]
7. [Mitoxantrone-aracytine with or without quinine in the treatment of refractory or relapsed acute leukemia]. Solary E, Witz F, Moreau P, Quiquandon I, Genne P, Flesch M, Saddoun A, Maloisel F, Pignon B, Abgrall JF. Nouv Rev Fr Hematol (1978); 1994 Jul 13; 36 Suppl 2():S141-3. PubMed ID: 7971263 [No Abstract] [Full Text] [Related]
10. [FAB classification, response to therapy, and survival in adult patients with acute leukemia (report II)]. Moriyama Y, Sato K, Narita M, Takeshige T, Saito H, Aoki S, Nakamori Y, Nagai K, Takizawa S, Soga N. Rinsho Ketsueki; 1984 Oct 13; 25(10):1587-93. PubMed ID: 6520936 [No Abstract] [Full Text] [Related]